Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
205.6 SEK | -0.29% |
|
0.00% | +61.76% |
05/07 | European Equities Traded in the US as American Depositary Receipts Rise in Friday Trading | MT |
05/07 | Calliditas Therapeutics' Partner Launches Japanese Trial for IgA Nephropathy Treatment | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+61.76% | 105.91Cr | |
+5.90% | 7.18TCr | |
+22.78% | 955.52Cr | |
+30.09% | 484.78Cr | |
-21.31% | 448.43Cr | |
+24.78% | 389.91Cr | |
+11.03% | 200.55Cr | |
-2.11% | 199.05Cr | |
-36.28% | 189.11Cr | |
-43.19% | 177.2Cr |
- Stock Market
- Equities
- CALTX Stock
- News Calliditas Therapeutics AB
- Calliditas Partner Starts Late-stage Trial for Kidney Disease Treatment